Geneious Product Updates

New feature highlights for Geneious Biologics include support for non-antibody therapeutic peptides and the ability to share your analysis options with your team.

• Analysis of non-antibody therapeutic peptides and proteins
• Easily accessible new Graphs tab
• Save and share analysis settings within your organization
• Better support for scFv/bi-specifics: Linker databases

Exciting new features for Geneious Biologics include manual sequence editing, dual nanobody (VHH-VHH) support, and protein scaffold reference databases.

• Manual Sequence Editing
• NGS Antibody Annotator
• Enrichment and Alignment Visualizations
• VHH and Dual Nanobody Analysis
• Reference Database Creator

Exciting new features for Geneious Biologics include:

• An improved user interface experience
• Positional Liabilities based on antibody numbering schemes
• Adding labels to a selection of sequences
• Clustering options now available in Single Clone Antibody Analysis
• New speedier integration with Geneious Prime

New features for Geneious Biologics include:

• More Numbering Schemes for annotation
• Streamlined Extract/Export Features
• Extract & Recluster
• Import Sequences from .csv and excel files

New features and functionality for Geneious Biologics includes:

• Customizable clustering options for Antibody Annotator
• History Viewer tab to track input data and more across documents
• Copy-paste sequences for Quick Analysis
• Chain Combinations tables in Single Clone Antibody Analysis

In Q2 2021 we have focused on improving visualizations and overall usability in Geneious Biologics. Highlights include Graph Usability Improvements, Moveable Folders, and REST API.

Geneious Biologics has introduced Searchable Collections to save curated lists of annotated antibody sequences, complete with assay data and other relevant sequence information.

Multi-region alignment improvements are now available in Geneious Biologics allowing you to align multiple regions at once, directly from the "All Sequences" result table.

We have recently released a number of features and improvements to Geneious Biologics including dynamic reporting, automated sequence repair and upload improvements.

Geneious Biologics has added new functionality designed to improve workflows for biologic drug development including visualizing similarity clusters in alignments, quickly summarizing families of sequences with sequence logos, and Unique Molecular Identifier (UMI) processing.